Scholarlink

Background: <p>The COVID-19 pandemic has affected the epidemiology of <i>Mycoplasma pneumoniae</i> pneumonia (MPP). This study aimed to provide a comprehensive overview of research trends, challenges, and advancements in pediatric MPP, particularly in the post-COVID-19 era.</p> Methods: <p>A bibliometric analysis of pediatric MPP literature (1992–2025) from the Web of Science was conducted using VOSviewer and CiteSpace.</p> Results: <p>A total of 2357 relevant articles were published by 11,318 authors from 2714 institutions across 94 countries. Publications increased significantly during and after the COVID-19 pandemic. China and the United States were the most influential countries, while Soochow University and Capital Medical University were the most active institutions. The top 10 co-cited references included four research articles and six review articles. Over the past 34 years, the research focus has shifted from community-acquired pneumonia (CAP) and pediatric pulmonary diseases to MPP. Current research hotspots include epidemiology, diagnostics, macrolide resistance, refractory MPP, and co-infections, with recent citation bursts related to COVID-19.</p> Conclusion: <p>This bibliometric analysis provides a systematic overview of pediatric MPP research from the 1990s to the post-COVID-19 era. It highlights the need for stronger global collaboration and further epidemiological studies to address MPP-related challenges, especially amid evolving infectious threats like COVID-19.</p> Impact <p><UnorderedList Mark="Bullet"> <ItemContent> <p>This study offers a comprehensive overview of pediatric <i>Mycoplasma pneumoniae</i> pneumonia (MPP) research from 1992 to 2025, revealing critical changes and advances in the field.</p> </ItemContent> <ItemContent> <p>Detailed analyses of core contributors, thematic evolution, research hotspots and frontiers advance the overall understanding of pediatric MPP.</p> </ItemContent> <ItemContent> <p>The findings reveal persistent challenges in epidemiology, diagnostics, macrolide resistance, refractory MPP, and co-infections.</p> </ItemContent> <ItemContent> <p>This study highlights the necessity of strengthening global collaboration and conducting continuous epidemiological surveillance on MPP amid emerging infectious threats such as COVID-19.</p> </ItemContent> <ItemContent> <p>These results provide valuable insights for addressing clinical challenges and developing novel therapeutic strategies.</p> </ItemContent> </UnorderedList></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Research progress and trends of Mycoplasma pneumoniae pneumonia in children: a bibliometric and visualization analysis (1990s to post-COVID-19 era)

  • 期刊论文

  • 发表日期：

    2026年7月11日

查看全文
  • Jing Xiao,
  • Yiyi Chen,
  • Weiwei Jiao,
  • Hui Qi,
  • Jinrong Liu,
  • Yuqing Wang,
  • Baoping Xu,
  • Ju Yin,
  • Chengsong Zhao,
  • Lin Sun

摘要

Background:

The COVID-19 pandemic has affected the epidemiology of Mycoplasma pneumoniae pneumonia (MPP). This study aimed to provide a comprehensive overview of research trends, challenges, and advancements in pediatric MPP, particularly in the post-COVID-19 era.

Methods:

A bibliometric analysis of pediatric MPP literature (1992–2025) from the Web of Science was conducted using VOSviewer and CiteSpace.

Results:

A total of 2357 relevant articles were published by 11,318 authors from 2714 institutions across 94 countries. Publications increased significantly during and after the COVID-19 pandemic. China and the United States were the most influential countries, while Soochow University and Capital Medical University were the most active institutions. The top 10 co-cited references included four research articles and six review articles. Over the past 34 years, the research focus has shifted from community-acquired pneumonia (CAP) and pediatric pulmonary diseases to MPP. Current research hotspots include epidemiology, diagnostics, macrolide resistance, refractory MPP, and co-infections, with recent citation bursts related to COVID-19.

Conclusion:

This bibliometric analysis provides a systematic overview of pediatric MPP research from the 1990s to the post-COVID-19 era. It highlights the need for stronger global collaboration and further epidemiological studies to address MPP-related challenges, especially amid evolving infectious threats like COVID-19.

Impact

This study offers a comprehensive overview of pediatric Mycoplasma pneumoniae pneumonia (MPP) research from 1992 to 2025, revealing critical changes and advances in the field.

Detailed analyses of core contributors, thematic evolution, research hotspots and frontiers advance the overall understanding of pediatric MPP.

The findings reveal persistent challenges in epidemiology, diagnostics, macrolide resistance, refractory MPP, and co-infections.

This study highlights the necessity of strengthening global collaboration and conducting continuous epidemiological surveillance on MPP amid emerging infectious threats such as COVID-19.

These results provide valuable insights for addressing clinical challenges and developing novel therapeutic strategies.